<?xml version="1.0" encoding="UTF-8"?>
<p class="p">The agar dilution method mirrored the one approved by CLSI [
 <xref rid="cit0018" ref-type="bibr" class="xref">18</xref>] with the following modification: a final concentration of 1.0% (v/v) Tween
 <sup class="sup">®</sup> 80 (Sigma-Aldrich, Germany) was incorporated into Mueller-Hinton Agar (MHA) (Sigma-Aldrich, Germany) after autoclaving in order to enhance FEO and 
 <italic class="italic">t</italic>A solubility. FEO and 
 <italic class="italic">t</italic>A at various concentrations (0.1%, 0.25%, 0.5%, 0.75%, 1.0%, 1.5%, 2.0%, 2.5%, 3.0%, 3.5%, 4.0%) (v/v) were independently transferred into MHA with 1.0% (v/v) Tween
 <sup class="sup">®</sup> 80. Plates were dried at 37°C for 30 min prior to inoculation of each them with suspension containing approximately 10
 <sup class="sup">4</sup> CFU/ml of particular 
 <italic class="italic">S. aureus</italic> isolates, using a multichannel pipette. MHA with 1.0% (v/v) Tween
 <sup class="sup">®</sup> 80 without FEO or 
 <italic class="italic">t</italic>A was used as a positive growth control for 
 <italic class="italic">S. aureus</italic>. Minimal inhibitory concentration (MIC) of each tested ingredient was determined after 18 h incubation and recognized as the lowest concentration of oil which completely inhibited the visible growth of 
 <italic class="italic">S. aureus</italic> on MHA plate. According to CLSI recommendations, a single colony or a faint haze caused by the inoculum was disregarded [
 <xref rid="cit0018" ref-type="bibr" class="xref">18</xref>].
</p>
